In another study, to enhance the efficacy of TMZ, polymer-micellar nanoparticles were developed for the co-delivery of TMZ and RG7388 (an inhibitor of glioblastoma multiforme DNA damage response systems) and covalently bound to the CD133 aptamer to target CSCs. This evidence concerns the gene PROM1 and glioblastoma.